BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mohme M, Neidert MC. Tumor-Specific T Cell Activation in Malignant Brain Tumors. Front Immunol 2020;11:205. [PMID: 32117316 DOI: 10.3389/fimmu.2020.00205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Mensali N, Inderberg EM. Emerging Biomarkers for Immunotherapy in Glioblastoma. Cancers (Basel) 2022;14:1940. [PMID: 35454848 DOI: 10.3390/cancers14081940] [Reference Citation Analysis]
2 Wang L, Sun W, Zhang G, Huo J, Tian Y, Zhang Y, Yang X, Liu Y. T-cell activation is associated with high-grade serous ovarian cancer survival. J Obstet Gynaecol Res 2022. [PMID: 35334503 DOI: 10.1111/jog.15234] [Reference Citation Analysis]
3 Mou Y, Zhang L, Liu Z, Song X. Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma. BMC Cancer 2022;22:215. [PMID: 35227235 DOI: 10.1186/s12885-022-09313-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Rivero-Hinojosa S, Grant M, Panigrahi A, Zhang H, Caisova V, Bollard CM, Rood BR. Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors. Nat Commun 2021;12:6689. [PMID: 34795224 DOI: 10.1038/s41467-021-26936-y] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
5 Melcher V, Kerl K. The Growing Relevance of Immunoregulation in Pediatric Brain Tumors. Cancers (Basel) 2021;13:5601. [PMID: 34830753 DOI: 10.3390/cancers13225601] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mitchell D, Shireman J, Sierra Potchanant EA, Lara-Velazquez M, Dey M. Neuroinflammation in Autoimmune Disease and Primary Brain Tumors: The Quest for Striking the Right Balance. Front Cell Neurosci 2021;15:716947. [PMID: 34483843 DOI: 10.3389/fncel.2021.716947] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Lee GA, Lin WL, Kuo DP, Li YT, Chang YW, Chen YC, Huang SW, Hsu JB, Chen CY. Detection of PD-L1 Expression in Temozolomide-Resistant Glioblastoma by Using PD-L1 Antibodies Conjugated with Lipid‑Coated Superparamagnetic Iron Oxide. Int J Nanomedicine 2021;16:5233-46. [PMID: 34366665 DOI: 10.2147/IJN.S310464] [Reference Citation Analysis]
8 Ma Y, Yang Z, Huntoon K, Jiang W, Kim BYS. Advanced Immunotherapy Approaches for Glioblastoma. Adv Therap 2021;4:2100046. [DOI: 10.1002/adtp.202100046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhou Q, Zhou J, Fan J. Expression and Prognostic Value of ARID5A and its Correlation With Tumor-Infiltrating Immune Cells in Glioma. Front Oncol 2021;11:638803. [PMID: 34094918 DOI: 10.3389/fonc.2021.638803] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Alghamri MS, McClellan BL, Hartlage MS, Haase S, Faisal SM, Thalla R, Dabaja A, Banerjee K, Carney SV, Mujeeb AA, Olin MR, Moon JJ, Schwendeman A, Lowenstein PR, Castro MG. Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments. Front Pharmacol 2021;12:680021. [PMID: 34084145 DOI: 10.3389/fphar.2021.680021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
11 Gangoso E, Southgate B, Bradley L, Rus S, Galvez-Cancino F, McGivern N, Güç E, Kapourani CA, Byron A, Ferguson KM, Alfazema N, Morrison G, Grant V, Blin C, Sou I, Marques-Torrejon MA, Conde L, Parrinello S, Herrero J, Beck S, Brandner S, Brennan PM, Bertone P, Pollard JW, Quezada SA, Sproul D, Frame MC, Serrels A, Pollard SM. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. Cell 2021;184:2454-2470.e26. [PMID: 33857425 DOI: 10.1016/j.cell.2021.03.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
12 Giotta Lucifero A, Luzzi S, Brambilla I, Trabatti C, Mosconi M, Savasta S, Foiadelli T. Innovative therapies for malignant brain tumors: the road to a tailored cure. Acta Biomed 2020;91:5-17. [PMID: 32608372 DOI: 10.23750/abm.v91i7-S.9951] [Cited by in F6Publishing: 7] [Reference Citation Analysis]